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Abstract  
 Respiratory tract infections are believed to be one of the main reasons 
peoplestill visits their GP or pharmacist.Respiratory tract infections (RTIs) 
are the leading cause of Death in USA. Thus, lower respiratory tract 
infections(LRIs) are generally more serious than upper respiratory infections. 
Specifically, the LRIs have been themajor cause of death among all 
infectious diseases. However, the two most common LRIs are bronchitis and 
pneumonia. Typical infections of the upper respiratory tract include 
tonsillitis, pharyngitis, laryngitis, sinusitisandotitis media. The aim of this 
study is to strengthen the surveys of the cases and the causes of 
therespiratory tract infection. This study also aims at evaluating the number 
of persons whohad negative result and the reason for the lack of screening of 
all pathogenic virus and search for bacterial infection only. In addition,this 
study finally carries out culture characterization and antibiotic susceptibility 
testing of the isolated pathogenic bacteria.  In order to attain these goals, we 
carried out a survey of 635 throat swabsand sputum sample between January 
2013 to December 2014 using throat and sputumin the Department of 
Microbiology at the Central Laboratory ofthe Ministry of Health in Amman- 
the capital of Jordan. In addition, culture and biochemical test and 
antiserawere also carried out. Atotal of 635individuals (275 males and 360 
females)swabs and sputumwere tested for bacterial infection, a total 55 
throat swabs showed positive results for Group A beta-hemolytic 
streptococci with an overall prevalence of 8.7 %.Also, a total of 23 sputum 
samplesshowed positive results for different types of bacterial infection with 
an overall prevalence of 10 %. After then, the result about their antibiotic 
susceptibility was reported. In conclusions, Group A beta-hemolytic 
streptococci isthe most common cause of the upper respiratory tract 
infection, whileK. pneumoniais the most common cause of lower respiratory 
tract infection. 
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Introduction  
 Respiratory tract infection refers to any number of infectious diseases 
involving the respiratory tract. An infection of this type is normally further 
classified as an upper respiratory tract infection (URI or URTI) or a lower 
respiratory tract infection (LRI or LRTI). Lower respiratory infections, such 
as pneumonia tends to be in a far more serious condition than upper 
respiratory infections, such as the common cold(Antibiotic, 2006).Although 
some disagreement exists on the exact boundary between the upper and 
lower respiratory tracts, the upper respiratory tract is generally considered to 
be the airway above the glottis or vocal cords. However, this includes the 
nose, sinuses, pharynx, and larynx. The lower respiratory tract consists of the 
trachea (wind pipe), bronchial tubes, the bronchioles and the lungs. Lower 
respiratory tract infections are generally more serious than upper respiratory 
infections. LRIs have been the leading cause of death among all infectious 
diseases (Antibiotic, 2006).Therefore, the two most common LRIs are 
bronchitis and pneumonia(Musher, 2003).Influenza affects both the upper 
and lower respiratory tracts, but more dangerous strains such as the highly 
pernicious H5N1 tend to bind tothe receptors deep in the lungs (VanRid, et al 
2006).Furthermore, the upper respiratory tract infection (URI) is a 
nonspecific term used to describe acute infections involving the nose, 
paranasal sinuses(Wilson, 2010), pharynx, larynx, trachea, and bronchi. The 
prototype is the illness known as common cold, which was discussed in this 
study in addition to pharyngitis, sinusitis and tracheobronchitis. Influenza is 
a systemic illness that involves the upper respiratory tract and should be 
differentiated from other URIs(Fendrick, et al 2003).Pharyngitis is an 
inflammation of the throat caused by a respiratory virus (rhinovirus, 
coronavirus, adenovirus, influenza virus, parainfluenza viruses, respiratory 
syncytial virus), Epstein–Barr virus or coxsackievirus(Kistler, et al 
2007).Also, bacterial pharyngitis is less commonand its single most frequent 
cause is S. pyogenes(Wessels, 2011).Other rare bacterial causes include 
Neisseriameningitidis, Mycoplasma pneumoniae, C. diphtheriae 
andArcanobacteriumhaemolyticum. Peak incidence is between autumn and 
spring in temperate climates, and during the rainy season in the tropics. 
However, transmission is more rapid among groups sharing crowded living 
quarters and can be by droplet spread or direct transmission. The 
investigation most frequently requested for pharyngitis is the detection of S. 
pyogenes(Kistler, et al 2007).This species is detected either by culture on 
blood agar and subsequent latex agglutination reaction for group-specific 
polysaccharide, or by direct antigen detection. Therefore, neither method can 
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distinguish oropharyngealcolonization from true infection, but only culture 
allows antibiotic susceptibility testing(Antibiotic, 2006). Suspicion of 
infection with N. gonorrhoea, Mycoplasma spp., Arcanobacterium sp. or 
Corynebacterium spp. should be communicated to the laboratory so that 
specialist non-routine culture media can be used. An oral penicillin or 
erythromycin is used to treat streptococcal pharyngitis(Bauer, 
2002).Treatment might not alter the course of the primary pharyngeal 
infection, but it should reduce the risk of major non-infective sequelae such 
as rheumatic heart disease, poststreptococcalglomeru- lonephritis and 
Sydenham’s chorea(Robert, et al 2004).The need for antibiotic treatment of 
streptococcal pharyngitis has been questioned in developed countries, since 
the non-infective sequelae of streptococcal infection are all rare. 
Nevertheless, the recent increase in streptococcal infection in Europe and 
North America may change this view(Antibiotic, 2006). The other 
complications of streptococcal pharyngitis includes scarlet fever (less 
common than in the past in developed countries), streptococcal toxic shock 
syndrome (both caused by toxin) and quinsy (paratonsillar abscess). In 
quinsy, there may be secondary infection with oral anaerobic bacteria, but 
these are often penicillin sensitive. In addition, the drainage of purulent foci 
is required.In order for the pathogens (viruses and bacteria) to invade the 
mucus membrane of the upper airways, they have to fight through several 
physical and immunologic barriers. Common lower RTIs include flu (this 
can affect either the upper or lower respiratory tract),bronchitis (infection of 
the airways),pneumonia (infection of the lungs),bronchiolitis (an infection of 
the small airways that affects babies and children younger than two) and 
tuberculosis (persistent bacterial infection of the lungs)(Wenzel, 2006). The 
main symptom of a lower RTI is cough, although it is usually more severe 
and you may bring up phlegm and mucus. Other possible symptoms are a 
tight feeling in your chest, increased rate of breathing, breathlessness and 
wheezing. RTIs can spread in several ways. If you have an infection such as 
a cold, tiny droplets of fluid containing the cold virus are launched into the 
air whenever you sneeze or cough. Thus, if someone else breaths these, they 
might also become infected. Infections can also be spread through indirect 
contact. For example, if you have a cold and you touch your nose or eyes 
before touching an object or surface, the virus may be passed to someone 
else when they touch that object or surface. The best way to prevent the 
spread of infection is to practice good hygiene, such as regularly washing 
your hands with soap and warm water. This is because most RTIs will pass 
out without the need for treatment, and you would not need to see your GP. 
However, you can treat your symptoms at home by taking over-the-counter 
painkillers such as paracetamol or ibuprofen[13], drinking plenty of fluids 
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and resting. Antibiotics are not recommended for most RTIs because they are 
only effective if the infection is caused by bacteria.  
 
Aim of the Study 
 The aim of this study is to strengthen the surveys of the cases and the 
causes of therespiratory tract infection.This study also aims at evaluatingthe 
number of persons who had negative result and the reason for the lack of 
screening for all pathogenic virus and search for bacterial infection only. 
However, this study finally conducted culture characterization and antibiotic 
susceptibility testing of the isolated pathogenic bacteria. 
 
Methods  
 From January 2013 to December 2014, a total of 635 individual (275 
males and 360females) swabs and sputum sampleswere testedat the 
Department of Microbiology at Central Laboratory of the Ministry of Health 
in Amman- the capital of Jordan.  Swabs were tested for Group A beta-
hemolytic streptococci.  Throat swabs were collected and sent to the 
laboratory for processing and analyses; and were processed following 
standard guidelines. Briefly, a loopful of each specimen was taken from the 
throat swab and inoculated on blood agar. The plates were incubated under 
aerobic conditions at 37 for 24-48 hours. Microscopic and macroscopic 
examinations of the growing colonies on the plates were performed. 
Suspicious colonies were then subcultured on a blood agar for purification. 
Preliminary identification was performed based on morphology and cultural 
characteristics of the pure cultures on selective and differential media as 
described by Cheesbrough. Also, it was described by subsequent latex 
agglutination reaction for group-specific polysaccharide, or by direct antigen 
detection and differential media as described by Cheesbrough. The API 20E 
kit (Biomerieux, France) was then used for the final confirmation. 
Furthermore, antibacterial susceptibility testing was performed using the 
Kirby-Bauer disc diffusion method as described by Bauer and co-
workers(Bauer, 2002).Briefly, for each isolate, a small inoculum was 
emulsified in 3 mL sterile normal saline. The density was then compared 
with a barium chloride standard (0.5 McFarland). A sterile cotton swab was 
dipped into the standardized solution of bacterial cultures and used for 
evenly inoculating Mueller-Hinton agar plates (Oxoid, USA) and were 
allowed to dry. Next, antibiotic discs with the following drug contents- 
ampicillin (10 g), cefuroxime (30 g), ceftriaxon gentamicin (10 g), t and 
penicillin (10 IU) (Oxoid, England) were placed on the plates, spacing them 
well to prevent the overlapping of inhibition zones. The plates were 
incubated at 37 for 24 hours, and the diameters of the zone of inhibition were 
compared with recorded diameters of thereference isolate. 
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Results  
 Atotal of 635 individuals (275 males and 360 females) swabs and 
sputumwere tested for bacterial infection. Also, a total of 55 throat swabs 
gave positive results for Group A beta-hemolytic streptococci with an overall 
prevalence of 8.7 % (Table 2). Furthermore, a total of 23 sputum 
samplesgavepositive results for different types of bacterial infection with an 
overall prevalence of 10 %. The seroprevalence in males was approximately 
double of that of females (10.9% vs. 6.9%)(Table 1).Thus, five   different 
types of bacteria were recovered: Pseudomonaseearuginosa(P. earuginosa), 
Klebsiellapneumoniae (K. pneumoniae), Streptococcuspneumoniae(S. 
pneumonia),PseudomonasEnterobacter, Acinetobacter and other bacteria 
like candida spp(Table  3). Also, the resistance patterns of the recovered 
bacteria isolates from respiratory tract infections(Table 4). 
Table 1: The Seroprevalence in males was approximately doublefor that of females (10.9% 
vs. 6.9%) 
Months Female Male 
January 2 2 
February 1 3 
March 3 4 
April 4 1 
May 0 2 
June 2 3 
July 3 1 
August 1 0 
September 3 1 
October 2 4 
November 2 3 
December 2 2 
Total 25 30 
Prevalence 6.9 10.9 
 
Table 2: The number of isolates of the upper respiratory bacteria pathogen 
Months Number of throat swab Group A beta-hemolytic streptococci 
January 52 4 
February 63 4 
March 64 7 
April 46 5 
May 55 2 
June 40 5 
July 68 8 
August 32 1 
September 90 4 
October 35 6 
November 60 5 
December 50 4 
Total 635 55 
Prevalence  8.7 
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Table 3: The number of isolates of the lower respiratory bacteria pathogen 
Months 
Numbe
r of 
sputum 
sample
s 
K. 
pneumoni
ae 
S. 
pneumon
ia 
Pseudomon
as 
Enterobact
er 
Acinetobact
er 
January 50 4 1 1 1 2 
February 35 6 2 1 2 1 
March 32 5 1 2 1 1 
April 40 3 3 1 1 1 
May 52 4 1 1 1 1 
June 60 2 2 1 0 0 
July 90 1 1 0 0 1 
August 64 1 4 0 1 0 
September 68 2 0 1 0 0 
October 64 0 1 0 0 1 
November 55 2 2 1 1 0 
December 50 1 0 0 0 1 
November 60 1 1 0 0 0 
December 47 3 0 0 0 0 
Total 635 35 19 9 8 9 
Prevalence  5.5 3 1.4 1.3 1.4 
 
Table 4:The resistance patterns of the recovered bacteria isolates from respiratory tract 
infections 
Antimicrobial 
agent 
s. 
pyogene
s 
K. 
pneumonia
e 
S. 
pneumonia
e 
Pseudomona
s 
Enterobacte
r 
Acinetobacte
r 
Cefuroxime 7.4( 5) 10.4 (6) 16.1(7) 35.5(9) 37.8(9) 30.1(6) 
Gentamycin 11.4(5) 7.9(5) 12.1(3) 20.6(5) 19.3(4) 15.7(5) 
Ampicillin 65.7 (29) 50.3(35) 56.8(19) 56.8(19) 65.6(8) 58.5(9) 
Cotrimoxazol
e 13.5(6) 60.0 (21) 65.8(10) 80.2(12) 82.3(9) 77.5(8) 
Erythromycin 40.1(15) 28.6 (10) 35.4(8) 45.3(6) 43.8(7) 32.1(6) 
vancomycin 9.1(10) 6.7(4) 11.5(4) 19.6(6) 17.5(6) 14.2(7) 
Penicillin 87.9(30) 85.2(32) 80.2(10) 90.1(7) 88.1(8) 85.4(9) 
Ciprofloxacin 14.5(22) 19.9(9) 17.2(4) 20.9(8) 21.3(7) 17.5(5) 
 
Discussion 
 The aim of this study is to strengthenthe surveys of the cases and the 
causes of the respiratory tract infection.This study aims at evaluating the 
number of persons who have negative result. Thus,it finally culture 
characterization and antibiotic susceptibility testing of the isolated 
pathogenic bacteria.  In order to reach those goals, we carried out a survey of 
635 throat swabs and sputum sample between January 2013 to December 
2014 using throat and sputumin the Department of Microbiology at Central 
Laboratory of the Ministry of Health in Amman - the capital of Jordan. In 
addition, culture and biochemical test and antisera were also carried out. 
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Atotal of 635 individuals (275 males and 360 females) swabs and 
sputumwere tested for bacterial infection, and a total of 55 throat swabs gave 
positive results for Group A beta-hemolytic streptococci with an overall 
prevalence of 8.7 %.In addition, a total of 23 sputum samples gave positive 
results for different types of bacterial infection with an overall prevalence of 
10 %.However, when reporting the information about their antibiotic 
susceptibilityfrom our results, we noted that males are more affected than 
females. This is because the males are more exposed to Environment 
pollution atwork. Also, we noted that the prevalence of bacterial is very low 
despite the patient is suffering from respiratory tract infection. However, this 
isthe reason for the lack of screening for all pathogenic virus and search for 
bacterial infection only. GroupA beta-hemolytic streptococci is themost 
common cause of the upper respiratory tract infection. However, different 
types of bacteria cause lower respiratory tract infection such 
asPseudomonaseearuginosa(P. earuginosa),  Klebsiellapneumoniae (K. 
pneumoniae), Streptococcuspneumonia (S. pneumonia ) 
,PseudomonasEnterobacter, Acinetobacter. Therefore, K. pneumoniais the 
most common cause of lower respiratory tract infection (table 3). Also, our 
study showed that the bacterial isolates were most sensitive to vancomycin 
followed by Cefuroxime and gentamicin. The bacteria isolates showed lower 
resistant to Ampicillin and penicillin because theantibiotics areabused 
without control.  
 
Conclusion 
 Group A beta-hemolytic streptococci is the most common causeofthe 
upper respiratory tract infection.ButK. pneumoniais the most common cause 
of the lower respiratory tract infection .  The prevalence of bacterial is very 
low despite in the patient suffer from respiratory tract infection. 
Consequently, this is the reason for the lack of screening for all pathogenic 
virus and search for bacterial infection only. The Susceptibility data obtained 
in our study provided information to the clinician when they want to make 
decisions on therapeutic options. In addition, the bacteria isolates showed 
lower resistant to Antibiotic,and the reason for that is that the antibiotics 
areabused without control.  
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